Titre : Déterminants sociaux de la santé

Déterminants sociaux de la santé : Questions médicales fréquentes

Termes MeSH sélectionnés :

Blood Component Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Déterminants sociaux de la santé : Questions médicales les plus fréquentes", "headline": "Déterminants sociaux de la santé : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Déterminants sociaux de la santé : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-20", "dateModified": "2025-04-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Déterminants sociaux de la santé" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Santé", "url": "https://questionsmedicales.fr/mesh/D006262", "about": { "@type": "MedicalCondition", "name": "Santé", "code": { "@type": "MedicalCode", "code": "D006262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N01.400" } } }, "about": { "@type": "MedicalCondition", "name": "Déterminants sociaux de la santé", "alternateName": "Social Determinants of Health", "code": { "@type": "MedicalCode", "code": "D064890", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mofya S Diallo", "url": "https://questionsmedicales.fr/author/Mofya%20S%20Diallo", "affiliation": { "@type": "Organization", "name": "Department of Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, Keck School of Medicine at the University of Southern California, 4650 Sunset Boulevard, MS#3, Los Angeles, CA 90027, USA. Electronic address: modiallo@chla.usc.edu." } }, { "@type": "Person", "name": "Sacharitha Bowers", "url": "https://questionsmedicales.fr/author/Sacharitha%20Bowers", "affiliation": { "@type": "Organization", "name": "Division of Dermatology, Department of Internal Medicine, Loyola University Medical Center, Stritch School of Medicine, 1S260 Summit Ave, Oakbrook Terrace, IL 60181, USA. Electronic address: sachbow@gmail.com." } }, { "@type": "Person", "name": "Aileen Y Chang", "url": "https://questionsmedicales.fr/author/Aileen%20Y%20Chang", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, University of California San Francisco, Zuckerberg San Francisco General Hospital, 995 Potrero Avenue, Building 90, Ward 92, San Francisco, CA 94110, USA." } }, { "@type": "Person", "name": "Christina Pardo", "url": "https://questionsmedicales.fr/author/Christina%20Pardo", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA. Electronic address: chp4022@med.cornell.edu." } }, { "@type": "Person", "name": "Julianne Holt-Lunstad", "url": "https://questionsmedicales.fr/author/Julianne%20Holt-Lunstad", "affiliation": { "@type": "Organization", "name": "Department of Psychology, Brigham Young University, Provo, Utah, USA; email: julianne_holt-lunstad@byu.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "An evaluation of a volumetric method for the flow cytometric determination of residual leukocytes in blood transfusion units.", "datePublished": "2022-12-19", "url": "https://questionsmedicales.fr/article/36534689", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0279244" } }, { "@type": "ScholarlyArticle", "name": "Non-severe allergic transfusion reaction: A hidden cause of wastage of blood product and laboratory resources.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36606422", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13397" } }, { "@type": "ScholarlyArticle", "name": "Risk factors for blood component therapy in parturients-Case-control study.", "datePublished": "2023-04-01", "url": "https://questionsmedicales.fr/article/37002925", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijgo.14747" } }, { "@type": "ScholarlyArticle", "name": "Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37102761", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/HC9.0000000000000147" } }, { "@type": "ScholarlyArticle", "name": "Implementation of a low-titre whole blood transfusion program in a civilian helicopter emergency medical service.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36494743", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13049-022-01051-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Caractéristiques de la population", "item": "https://questionsmedicales.fr/mesh/D011154" }, { "@type": "ListItem", "position": 3, "name": "Santé", "item": "https://questionsmedicales.fr/mesh/D006262" }, { "@type": "ListItem", "position": 4, "name": "Déterminants sociaux de la santé", "item": "https://questionsmedicales.fr/mesh/D064890" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Déterminants sociaux de la santé - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Déterminants sociaux de la santé", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Déterminants sociaux de la santé", "description": "Comment évaluer l'impact des déterminants sociaux sur la santé ?\nQuels outils mesurent les déterminants sociaux de la santé ?\nQuels indicateurs sont utilisés pour le diagnostic social ?\nComment les inégalités sociales affectent-elles la santé ?\nQuel rôle joue l'environnement dans le diagnostic social ?", "url": "https://questionsmedicales.fr/mesh/D064890?mesh_terms=Blood+Component+Transfusion&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Déterminants sociaux de la santé", "description": "Quels symptômes peuvent indiquer des déterminants sociaux défavorables ?\nComment la pauvreté affecte-t-elle la santé mentale ?\nQuels symptômes physiques sont liés à des conditions sociales ?\nLes inégalités sociales provoquent-elles des symptômes spécifiques ?\nComment l'accès limité aux soins se manifeste-t-il ?", "url": "https://questionsmedicales.fr/mesh/D064890?mesh_terms=Blood+Component+Transfusion&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Déterminants sociaux de la santé", "description": "Quelles stratégies de prévention ciblent les déterminants sociaux ?\nComment sensibiliser aux déterminants sociaux de la santé ?\nQuel rôle des communautés dans la prévention ?\nComment les politiques publiques influencent-elles la prévention ?\nQuels programmes de prévention sont efficaces ?", "url": "https://questionsmedicales.fr/mesh/D064890?mesh_terms=Blood+Component+Transfusion&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Déterminants sociaux de la santé", "description": "Comment adapter les traitements aux déterminants sociaux ?\nQuels traitements sont efficaces pour les populations défavorisées ?\nComment les services de santé peuvent-ils réduire les inégalités ?\nQuel rôle joue l'éducation dans le traitement des maladies ?\nComment les politiques de santé influencent-elles les traitements ?", "url": "https://questionsmedicales.fr/mesh/D064890?mesh_terms=Blood+Component+Transfusion&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Déterminants sociaux de la santé", "description": "Quelles complications sont liées aux inégalités sociales ?\nComment les déterminants sociaux aggravent-ils les maladies ?\nQuels sont les effets à long terme des déterminants sociaux ?\nComment prévenir les complications liées aux déterminants sociaux ?\nLes complications de santé sont-elles évitables ?", "url": "https://questionsmedicales.fr/mesh/D064890?mesh_terms=Blood+Component+Transfusion&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Déterminants sociaux de la santé", "description": "Quels sont les principaux facteurs de risque sociaux ?\nComment l'éducation influence-t-elle les facteurs de risque ?\nQuel impact a l'emploi sur la santé ?\nComment l'environnement social affecte-t-il la santé ?\nQuels facteurs de risque sont liés à l'accès aux soins ?", "url": "https://questionsmedicales.fr/mesh/D064890?mesh_terms=Blood+Component+Transfusion&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact des déterminants sociaux sur la santé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact peut être évalué par des études épidémiologiques et des enquêtes sociales." } }, { "@type": "Question", "name": "Quels outils mesurent les déterminants sociaux de la santé ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires standardisés et des indices de conditions de vie sont utilisés." } }, { "@type": "Question", "name": "Quels indicateurs sont utilisés pour le diagnostic social ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent le revenu, l'éducation, et l'accès aux soins de santé." } }, { "@type": "Question", "name": "Comment les inégalités sociales affectent-elles la santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les inégalités sociales peuvent entraîner des disparités dans l'accès aux soins et la santé." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement dans le diagnostic social ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'environnement physique et social influence la santé par l'accès aux ressources." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer des déterminants sociaux défavorables ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes de stress, dépression ou maladies chroniques peuvent apparaître." } }, { "@type": "Question", "name": "Comment la pauvreté affecte-t-elle la santé mentale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La pauvreté peut entraîner une augmentation de l'anxiété et de la dépression." } }, { "@type": "Question", "name": "Quels symptômes physiques sont liés à des conditions sociales ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies comme l'hypertension et le diabète peuvent être exacerbées par des conditions sociales." } }, { "@type": "Question", "name": "Les inégalités sociales provoquent-elles des symptômes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des symptômes de maladies évitables et chroniques." } }, { "@type": "Question", "name": "Comment l'accès limité aux soins se manifeste-t-il ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il se manifeste par des symptômes non traités et des complications de santé." } }, { "@type": "Question", "name": "Quelles stratégies de prévention ciblent les déterminants sociaux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes d'éducation, d'accès aux soins et de soutien communautaire sont essentiels." } }, { "@type": "Question", "name": "Comment sensibiliser aux déterminants sociaux de la santé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Par des campagnes d'information et des formations pour les professionnels de santé." } }, { "@type": "Question", "name": "Quel rôle des communautés dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les communautés peuvent mobiliser des ressources et créer des réseaux de soutien." } }, { "@type": "Question", "name": "Comment les politiques publiques influencent-elles la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent promouvoir l'équité en santé et améliorer l'accès aux services." } }, { "@type": "Question", "name": "Quels programmes de prévention sont efficaces ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les programmes intégrés qui abordent plusieurs déterminants sociaux sont les plus efficaces." } }, { "@type": "Question", "name": "Comment adapter les traitements aux déterminants sociaux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements doivent tenir compte des ressources et des conditions de vie des patients." } }, { "@type": "Question", "name": "Quels traitements sont efficaces pour les populations défavorisées ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les programmes de santé communautaire et les interventions ciblées sont efficaces." } }, { "@type": "Question", "name": "Comment les services de santé peuvent-ils réduire les inégalités ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "En offrant des soins accessibles et adaptés aux besoins des populations vulnérables." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation dans le traitement des maladies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation améliore l'adhésion aux traitements et la gestion des maladies." } }, { "@type": "Question", "name": "Comment les politiques de santé influencent-elles les traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles déterminent l'accès aux soins et les ressources disponibles pour les traitements." } }, { "@type": "Question", "name": "Quelles complications sont liées aux inégalités sociales ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies chroniques non traitées et des décès prématurés." } }, { "@type": "Question", "name": "Comment les déterminants sociaux aggravent-ils les maladies ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent entraîner un accès limité aux soins et une mauvaise gestion des maladies." } }, { "@type": "Question", "name": "Quels sont les effets à long terme des déterminants sociaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent mener à des problèmes de santé persistants et à une qualité de vie réduite." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux déterminants sociaux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En améliorant l'accès aux soins et en renforçant les réseaux de soutien communautaire." } }, { "@type": "Question", "name": "Les complications de santé sont-elles évitables ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses complications peuvent être évitées par des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque sociaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la pauvreté, le manque d'éducation et l'isolement social." } }, { "@type": "Question", "name": "Comment l'éducation influence-t-elle les facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Une éducation supérieure est associée à une meilleure santé et à des comportements préventifs." } }, { "@type": "Question", "name": "Quel impact a l'emploi sur la santé ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un emploi stable améliore la santé mentale et physique, réduisant les risques." } }, { "@type": "Question", "name": "Comment l'environnement social affecte-t-il la santé ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement social positif favorise le bien-être et réduit les risques de maladies." } }, { "@type": "Question", "name": "Quels facteurs de risque sont liés à l'accès aux soins ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le manque d'accès aux soins médicaux et préventifs augmente les risques de maladies." } } ] } ] }

Sources (10000 au total)

Non-severe allergic transfusion reaction: A hidden cause of wastage of blood product and laboratory resources.

Blood transfusions are often needlessly aborted following a non-severe allergic reaction despite responding well to medication resulting into partial transfusion of the implicated blood product. This ... We aimed to review the amount of blood product and laboratory resource wastage associated with non-severe allergic transfusion reaction (ATR) in a tertiary care hospital.... A total of 174,632 blood products were released and transfused during the study period (2019-2021). There were 336 adverse transfusion reactions with an estimated rate of 1.9 per 1000 blood products a... Non-severe ATR was found to be associated with a significant proportion of laboratory resource wastage and that of blood product in our institution. Revision of institutional guidelines for management...

Risk factors for blood component therapy in parturients-Case-control study.

Postpartum hemorrhage is a major cause of maternal morbidity and mortality, so early identification of patients at risk is crucial. In this study, we aim to assess the risk factors for major transfusi... A case-control study was conducted between 2011 and 2019. The cases included women who were treated with postpartum major transfusion compared with two control groups, one of which was treated with 1-... Of the 187 424 deliveries included in the present study, 246 (0.3%) women were treated with major transfusions. After applying a multivariate analysis, maternal age (odds ratio [OR] 1.07, 95% confiden... Retained placenta and antenatal anemia (hemoglobin < 10 g/dL) are independent risk factors for major transfusion. Of these, anemia was found to be the most significant....

Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey.

Recent guidelines recognize the limitations of standard coagulation tests in predicting bleeding and guiding pre-procedural blood component prophylaxis in cirrhosis. It is unclear whether these recomm... We designed a 36-item multiple-choice questionnaire to investigate the international normalized ratio and platelet cutoffs utilized to guide pre-procedural transfusion of fresh frozen plasma and plate... Overall, 48 specialists across Australia completed the questionnaire: 21 gastroenterologists, 22 radiologists, and 5 hepatobiliary surgeons. 50% of respondents reported that their main workplace did n... Our survey reveals significant heterogeneity of pre-procedural prophylactic transfusion practices in patients with cirrhosis and discrepancies between guidelines and clinical practice....

Implementation of a low-titre whole blood transfusion program in a civilian helicopter emergency medical service.

Early balanced transfusion is associated with improved outcome in haemorrhagic shock patients. This study describes the implementation and evaluates the safety of a whole blood transfusion program in ... This prospective observational study was performed over a 5-year period at HEMS-Bergen, Norway. Patients in haemorrhagic shock receiving out of hospital transfusion of low-titre Group O whole blood (L... The HEMS responded to 5124 patients. Seventy-two (1.4%) patients received transfusions. Twenty patients (28%) were excluded due to lack of consent (16) or not meeting the inclusion criteria (4). Of th... Implementing a whole blood transfusion program in civilian HEMS is feasible and safe and the logistics around out of hospital whole blood transfusions are manageable. Trial registration The study is r...

Blood component ratios in children with non-traumatic life-threatening bleeding.

In paediatric trauma patients, there are limited prospective data regarding blood components and mortality, with some literature suggesting decreased mortality with high ratios of plasma and platelets... This is a secondary analysis of the five-year, multicentre, prospective, observational massive transfusion epidemiology and outcomes in children study of children with life-threatening bleeding from U... A total of 222 children were included from 24 medical centres: 145 children (median [interquartile range] age 2.1 years [0.3-11.8]) with operative bleeding and 77 (8.0 years [1.2-14.7]) with medical b... This paper addresses a lack of prospective data in children regarding optimal empiric massive transfusion strategies in non-traumatic massive haemorrhage and in finding no decrease in mortality with h...

Evaluation of a rail logistics transmission system for the transportation of blood components within a medical centre.

Rail logistics transmission systems (RLTSs) are commonly used for the transportation of blood samples, pathological specimens and other medical materials in many hospitals, as they are rapid, secure, ... The dispatch of blood components, including packed red blood cells (pRBCs), fresh frozen plasma (FFP), cryoprecipitate and platelet units, from a blood bank to critical care areas or general wards was... The turnaround time and temperature of all tested blood units via RLTS transportation were able to meet the clinical demands of blood component delivery (median time: 323 s [118-668 s]; temperature va... Hospital-wide delivery of blood components via RLTS seems to be safe, reliable and cost-effective and does not have any negative impact on blood quality. Therefore, the establishment of standard crite...

Multi-center Retrospective Study of Factors Affecting Perioperative Transfusion of Packed Red Blood Cells for Pelvic Fracture Patients.

To analyze the use of packed red blood cells (PRBCs) for patients with pelvic fracture and evaluate factors associated with PRBC transfusion for patients with pelvic fracture.... This retrospective cohort study collected 551 patients with pelvic fractures from six hospitals between September 1, 2012, and June 31, 2019. The age span of patients varied from 10 to 95 years old, a... A total of 551 patients were screened from six hospitals, and after inclusion and exclusion, 319 were finally included and finished the follow-up from admission to discharge, while four patients died ... Patients with HE-PFs had increased transfusions of PRBCs, FFP, and albumin, and hemorrhagic shock on admission, Tile classification, Hb levels, and stabilization methods were found to be associated wi...

Hepatitis A virus (HAV) RNA detection in Polish blood donors and likely transmissions through blood components during the 2017-2019 epidemic.

In Poland, hepatitis A virus (HAV) RNA screening was performed in plasma for fractionation usually immediately before shipment.... Our goal was to study epidemiology, rate of transfusion transmitted HAV during epidemic (2017-2019), and viral characteristics of infected plasma donors.... HAV RNA was tested in 1,866,590 donations from 1,210,423 donors using RT-PCR in mini pools of 96 (MP96) or TMA in MP16. Virological characteristics included RNA level (RL), antibody testing, and seque... Twenty-one HAV infections were identified (1.13/100,000 donations; 95% confidence interval [95% CI]: 0.74-1.72) and (1.73/100,000 donors; 95% CI: 1.35-2.65). The Blood Transfusion Centers were also in... Based on our results, we propose a 6 month deferral after HAV infection and 14 days post HAV vaccination. The infectivity rate was below 30%. The HAV RNA testing could be considered as an additional s...

Demographics and appropriateness of cellular blood component irradiation practices: Ambispective analysis from a tertiary care center.

Transfusion-associated graft versus host disease (TA-GVHD) is often underreported. There may also be lapses in TA-GVHD prevention practices due to lack of revision of some of the existing clinical gui... Study cohort was selected from patients requiring transfusion support during June 2019 to May 2020. Transfusion history of these patients were followed, both retrospectively and prospectively till Jul... Total 6963 requisitions for cellular blood components were received from 255 patients included in the study cohort. Of these, 3690 (54.9 %) were IR requisitions, while remaining 3029 (45.1 %) requisit... Many units were unnecessarily irradiated (7.7 %) while irradiation was missed in 16 % of the requisitions included in analysis which may be attributed to lack of institutional guidelines. We recommend...